SEARCH RESULTS FOR: "Tag: AMRN"
REFINE YOUR SEARCH:
RECENT
Last Week(1)
Last Month(2)
ARTICLES/BLOGS
2019(1)
2018(6)
2015(3)
CATEGORIES
Analyst Update(1)
Buzz Stocks(1)
General(3)
Midday Market Check(1)
Quantitative Analysis(2)
Stocks On the Move(3)
Constellation Brands Stock Rallies on Big Upgrade
https://www.schaeffersresearch.com/content/news/2019/01/10/constellation-brands-stock-rallies-on-big-upgrade
1/10/2019 2:57 PM
Stocks are cautiously higher, but gains are capped by subpar holiday sales data. Among stocks making notable moves higher today are beer maker Constellation Brands, Inc. (NYSE:STZ), cardiovascular di...
2 Pharma Stocks Flashing Bullish Signals
https://www.schaeffersresearch.com/content/analysis/2018/12/19/2-pharma-stocks-flashing-bullish-signals
12/19/2018 12:30 PM
Despite today's gains, the healthcare sector has been under pressure lately amid the recent Obamacare court ruling. If history is any guide though, there could be clear skies ahead for blue chip Merc...
Signs Point to Short Squeeze for Solar Stock
https://www.schaeffersresearch.com/content/news/2018/11/27/signs-point-to-short-squeeze-for-solar-stock
11/27/2018 3:15 PM
The U.S. stock market has made a move higher in the last hour of trading. A number of individual stocks are making notable moves, too, including cardiovascular disease specialist Amarin Corporation...
Downgraded Apple Drags Dow Into the Red
https://www.schaeffersresearch.com/content/ezines/2018/11/14/downgraded-apple-drags-dow-into-the-red
11/14/2018 11:48 AM
The Dow Jones Industrial Average (DJI) was up more than 200 points earlier after this morning's latest inflation update. However, the blue-chip index has since swung into the red at midday, pressu...
Drug Trial Concerns Weigh on Amarin Stock
https://www.schaeffersresearch.com/content/news/2018/11/12/drug-trial-concerns-weigh-on-amarin-stock
11/12/2018 10:04 AM
The shares of Amarin Corporation (NASDAQ:AMRN) are down 10.6% to trade at $18.82 this morning, after an update on the pharmaceutical name's heart disease drug Vascepa. Data from a clinical trial showe...
Welcome to Schaeffer's Investment Research! We are a privately held provider of stock and options trading recommendations, options education, and market commentary, headquartered in Cincinnati, Ohio. Founded in 1981 by industry pioneer Bernie Schaeffer, we've since become a trusted source of research and analysis for individual investors and major financial media outlets alike.
More About
Schaeffer's
Contact
Us
Partner Center